Keywords: eisai, aricept, cerebrovascular, dementia, japan, completed, phase

Eisai 's Aricept for cerebrovascular dementia

Article | 08 November 2001

Print This

Eisai of Japan has completed Phase II testing of its Alzheimer's drugAricept (donepezil) in the treatment of cerebrovascular dementia, a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in